Akers Biosciences (AKER) Merger Partner MyMD Pharmaceuticals Announces Plans to Initiate COVID-19 Inflammatory Depression Trial
Go back to Akers Biosciences (AKER) Merger Partner MyMD Pharmaceuticals Announces Plans to Initiate COVID-19 Inflammatory Depression Trial| AKERS BIOSCIENCES (NASDAQ: AKER) | Delayed: 2.47 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.47 | 52 Week High | $3.70 | |||
| Open | $15.34 | 52 Week Low | $1.08 | |||
| Day High | $2.47 | P/E | N/A | |||
| Day Low | $2.47 | EPS | $0.00 | |||
| Volume | 9,440 | |||||
